Skip to content

Assessment of Novel Sound Changing Principles in Hearing Instruments to Determine Their Application - 2018_12

Assessment of Novel Sound Changing Principles in Hearing Instruments to Determine Their Application

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03554577
Enrollment
15
Registered
2018-06-13
Start date
2018-05-28
Completion date
2018-10-02
Last updated
2018-11-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hearing Loss

Brief summary

A methodical evaluation of novel sound changing principles in CE-labelled Sonova brand hearing instruments (e.g. Phonak hearing instruments) is intended to be conducted on hearing impaired participants. These sound changing principles are enabled by respective hearing instrument technologies and hearing instrument algorithms. The aim of the study is to investigate and asses strength and weaknesses of these novel sound changing principles in terms of hearing performance to determine their application in hearing instruments (Phase of development). Both, objective laboratory measurements as well as subjective evaluations in real life environment will be carried out. This will be a controlled, single blinded and randomised active comparator clinical evaluation which will be conducted mono centric at Sonova AG Headquarter based in Stäfa

Interventions

DEVICEHearing Aid without NR

Each participant will be fitted with the 4 different Noise Reduction (Sound Changing) principles on the same hearing aid, saved to 4 manual programs. Noise Reduction principle is a sound processing algorithm to remove noise from a speech signal to improve the speech intelligibility and comfort. The experimental conditions vary in their parametrization to result in different degrees of noise suppression and good speech quality.

DEVICEHearing Aid with NR_A

Each participant will be fitted with the 4 different Noise Reduction (Sound Changing) principles on the same hearing aid, saved to 4 manual programs. Noise Reduction principle is a sound processing algorithm to remove noise from a speech signal to improve the speech intelligibility and comfort. The experimental conditions vary in their parametrization to result in different degrees of noise suppression and good speech quality.

DEVICEHearing Aid with NR_B

Each participant will be fitted with the 4 different Noise Reduction (Sound Changing) principles on the same hearing aid, saved to 4 manual programs. Noise Reduction principle is a sound processing algorithm to remove noise from a speech signal to improve the speech intelligibility and comfort. The experimental conditions vary in their parametrization to result in different degrees of noise suppression and good speech quality.

DEVICEHearing Aid with NR_C

Each participant will be fitted with the 4 different Noise Reduction (Sound Changing) principles on the same hearing aid, saved to 4 manual programs. Noise Reduction principle is a sound processing algorithm to remove noise from a speech signal to improve the speech intelligibility and comfort. The experimental conditions vary in their parametrization to result in different degrees of noise suppression and good speech quality.

Sponsors

Sonova AG
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Intervention model description

Each participant will be treated with each sound changing principle (Noise Reduction principle (NR)) in a randomized order.

Eligibility

Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
No

Inclusion criteria

* Healthy outer ear (without previous surgical procedures) * Ability to fill in a questionnaire conscientiously * Informed Consent as documented by signature

Exclusion criteria

* Contraindications to the MD in this study, e.g. known hypersensitivity or allergy to the investigational product * Limited mobility and not in the position to attend weekly appointments * Limited ability to describe listening impressions/experiences and the use of the hearing aid * Inability to produce a reliable hearing test result * Massively limited dexterity * Known psychological problems * Known central hearing disorders * colour blinded

Design outcomes

Primary

MeasureTime frameDescription
Sound quality ratings4 weeksThe sound quality ratings will be assessed with the aid of a Multi-Stimulus Test. The data, serving as the primary outcome measure, are collected in the laboratory and will use a continuous rating scale. The scale ranges from 0 very bad to 100 very good in increments of 1.

Secondary

MeasureTime frameDescription
Oldenburg sentence test & manual tracking task4 weeksA dual task paradigm will be used in which the Oldenburg Sentence test in noise will be administered as a primary task, and the subject will manually track a point on a computerised elliptical track as a secondary task. The aim is to recall as many words from the presented sentence at a predefined SNR and track the point as accurately as possible at the same time. The SNR is set as the level at which a subject reaches a speech reception threshold of 80-90%. The data derived, serving as a secondary outcome measure, are a \[%\] of time on target and distance error from the target.
Oldenburg sentence test in noise4 weeksThe data, serving as secondary outcome is a Signal to noise ratio (SNR) in decibel (dB) where a 50% speech reception threshold is reached. This outcome measurement will be carried out in the laboratory.
Adaptive Categorial Listening Effort Scaling (ACALES)2 weeksThe ACALES procedure determines self-reported individual listening effort on a scale from extreme effort to no effort within a signal-to-noise ratio range that corresponds to individual subject perceptions. The data, serving as a secondary outcome, are a set of points on a categorial scale (subjectively perceived listening effort) as a function of different SNRs.
Self-report formOne weekA qualitative questionnaire with predefined questions and comment sections to gather information on individual perceptions regarding the comparison of two different hearing programs during different laboratory-based acoustic scenes. For details of the hearing aid settings, see study arms. The data collected from this questionnaire are scores on a continuous rating scale ranging from hearing program A is much worse than hearing program B to hearing program B is much better than hearing program A and any subjective comments given.

Other

MeasureTime frameDescription
color-word-interference test by J.R.Stroop1 weekThe color-word- interference test (Farb-Wort-Interferenztest nach J.R.Stroop (version: Günther Bäumler)) is a neuropsychological test of visual attention and interferer suppression and will be carried out in the laboratory. In the first trial, the subject has to read the names of colours written on a card as fast and accurately as possible. In the second trial, the subject has to name the colour ink of filled boxes on a card as quickly and accurately as possible. In the third trial, the names of colours are written on a card in a dissimilarly coloured ink. The participant must read aloud the written words, whilst ignoring the colour of the ink. The data, serving as an outcome measure, are time-to-complete the sets in seconds.
Non-verbal Trail Making Test A & B1 weekThe Trail Making Test is a neuropsychological test of visual attention and task switching. It consists of two parts in which the subject is instructed to connect a set of 25 dots as quickly as possible while still maintaining accuracy. The data, serving as an outcome measure, are time-to-complete the set in seconds.
Interaural Phase Difference (IPD) Detection thresholds1 weekA 2 Interval - 2 Alternative Forced Choice task to measure the psychometric function of IPD detection with changing stimulus frequency. The data, serving as an outcome measure, is the individual interaural phase difference (IPD) frequency threshold (the frequency up to which 75% correct answers are given).

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026